Rosselkhoznadzor suspends Vakkamast batch 300726 and Metrobiotik batch 15 across Eurasian Economic Union
The suspension of circulation within the Eurasian Economic Union (EAEU) affects batch 300726 of Vakkamast, manufactured by Agrofarm, and batch 15 of Metrobiotik, manufactured by BioKhimFarm.
Testing of Vakkamast found that the mass fraction of lincomycin hydrochloride did not meet the required standard. The stated expiry date for this batch is June 2028.
The tested batch of Metrobiotik failed to meet specifications for three parameters: average tablet weight, oxytetracycline hydrochloride content and nystatin content. This batch expires in April 2028.
Regional veterinary services have been notified of the suspension of circulation of these medicines. Rosselkhoznadzor asks that its territorial offices be notified if the banned batches are found on sale.
Vakkamast is intended to treat mastitis in lactating cows. Metrobiotik is used to treat uterine inflammation in cows and sows following obstetric assistance, surgical removal of the placenta, abortions, and complicated or abnormal births. Its indications include acute postpartum endometritis.




